Relative Bioavailability of Sorafenib Tablet for Oral Suspension

Status Completed

Clinical Trial Summary

The primary objective of the study is to

• Investigate the relative bioavailability of sorafenib as 400 mg (4 x 100 mg) tablet for oral suspension formulation in comparison to 400 mg (2 x 200 mg) marketed tablet formulation.

The secondary objectives of this study are to

- Evaluate the dose proportionality in sorafenib pharmacokinetics for sorafenib tablet for oral suspension formulation after administration of 200 mg (2 x 100 mg) and 400 mg (4 x 100 mg) dose of sorafenib in fasted state

- Evaluate the effect of food on the pharmacokinetics of the tablet for oral suspension formulation after administration of a single dose of 400 mg sorafenib (4 x 100mg)

- Evaluate the taste and palatability of sorafenib (both formulations)

- Assess the safety and tolerability of sorafenib tablet for oral suspension in healthy male subjects

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Biological Availability

Clinical Trial Details

NCT number	NCT02538393
Study type	Interventional
Source	Bayer
Contact
Status	Completed
Phase	Phase 1
Start date	November 20, 2015
Completion date	June 15, 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05544786` - Relative Bioavailability Study of Nirmatrelvir/Ritonavir Oral Powder Relative to the Commercial Tablets and Estimation of the Effect of Food on Bioavailability of the Nirmatrelvir/Ritonavir Oral Powder in Healthy Participants.	Phase 1
Completed	`NCT04744233` - Bioavailability of Carotenoids From Orange Juice in a Cross-over Study in Healthy Subjects.	N/A
Completed	`NCT05561075` - Oral Bioavailability of Pterostilbene Cocrystal Compared to Its Free Form (BIOPTERO)	N/A
Completed	`NCT03873909` - Bioavailability of Carotenoids Present in Mamey Sapote (Pouteria Sapota (Jacq.) H. E. Moore & Stearn) Fruit	N/A
Completed	`NCT03353857` - Drug-drug Interaction Between Rifampicin and Progestins/Ethinylestradiol and Midazolam	Phase 1
Completed	`NCT05121506` - A Study to Investigate the Bioavailability and Skin Absorption of CBD and THC From GT4 Technology in Healthy Adults	Phase 1
Completed	`NCT01267201` - A Study Comparing Drug Availability Of Methylprednisolone In Liquid Form Versus Methylprednisolone In Tablet Form	Phase 1
Completed	`NCT05116982` - Effect of Three Silicon Based Food Supplements on the Urinary Excretion of Aluminum and Other Metals (SILIAL)	N/A
Completed	`NCT04207372` - Protein Digestibility of Whey and Zein.	N/A
Completed	`NCT01853800` - Relative Bioavailability of Oral Suspension of Rivaroxaban Compared to Standard Tablet	Phase 1
Completed	`NCT00714584` - Pharmacokinetics of Naltrexone Following Intravenous and Oral Routes of Administration in Healthy Volunteers	Phase 1
Completed	`NCT04876261` - Bioavailability of Hydroxytyrosol From Olive Watery Extract Supplements	N/A
Completed	`NCT03886597` - Nutritional Intervention With Table Olives in Healthy Volunteers	Phase 1/Phase 2
Completed	`NCT06289140` - Oral Bioavailability of a New Formulation of Pterostilbene Cocrystal in Comparison With Its Free Form (BIOPTERO2)	N/A
Completed	`NCT05439408` - Comparative Bioavailability of XS004 (Dasatinib) Formulation G and SPRYCEL® (Dasatinib) in Healthy, Adult Subjects Under Fasting Conditions	Phase 1
Completed	`NCT03951025` - Study of the Bioavailability of a Food Supplement Rich in Melatonin Administered Sublingually and Orally (MELATONIN)	Phase 2
Completed	`NCT03984916` - Study of the Bioavailability of Three Hesperidin Extracts.	N/A
Completed	`NCT02966704` - Stable Isotope Method to Assess Dietary Protein Quality	N/A
Completed	`NCT02847117` - Bioavailability of the Microconstituents of Natural Chios Mastiha in Healthy Adults.	N/A
Completed	`NCT03048110` - Drug-drug Interaction (DDI) Study to Assess ODM-201 as a Victim of CYP3A4 Inhibition or Induction	Phase 1